
Scientists have found that the same supplement millions of gym-goers scoop into their shakes each morning may also help repair the damaged lining of an inflamed gut.
Story Snapshot
- Colon tissue from patients with ulcerative colitis and Crohn’s disease shows lower levels of the creatine transporter than healthy tissue.
- Lab experiments show creatine helps intestinal cells make energy and keep the gut’s protective barrier intact.
- Animal studies found oral creatine eased colitis symptoms, including gut damage and related anxiety and depression behaviors.
- No finished human clinical trial has yet proven creatine treats inflammatory bowel disease in patients.
A Transporter Problem Hiding In Damaged Colons
Researchers examining human colon samples found something unexpected. Tissue from patients with ulcerative colitis and inactive Crohn’s disease carried far less of the gene that builds the creatine transporter than tissue from healthy people. That transporter is the doorway creatine uses to get inside intestinal cells. Without enough of it, cells may struggle to store the fuel they need to keep the gut lining sealed and functioning properly.
That doorway problem matters because intestinal cells burn through energy fast. They constantly rebuild themselves, heal small wounds, and hold the barrier together. Follow-up experiments on lab-grown gut cells and tiny gut organoids showed that adding back a creatine-based fuel source rescued cells from energy deficits, restoring their ability to grow, heal scratches, and form a working barrier.
Other researchers traced the wiring behind this fuel system. They found that creatine kinase genes, the engines that convert creatine into usable energy, are switched on by the body’s oxygen-sensing machinery, and that this switch is essential for sealing the junctions between gut cells. Mice bred without working creatine kinase genes got sicker faster in a colitis model, losing more weight and suffering more gut damage than normal mice. The pattern across species points the same direction.
From Petri Dish To Lab Rats
Cell studies are one thing. Whole-animal results carry more weight, and researchers have started supplying it. Rats given chronic colitis and then fed oral creatine showed less severe gut injury than untreated rats. The treated animals also avoided some of the motor problems, anxiety, and depression-like behavior that often come with long-term gut inflammation.
A separate study pushed the connection even further, into the brain. Chronic colitis in mice triggered inflammation and nerve damage in the hippocampus, the brain region tied to memory and mood. Creatine supplementation blunted that damage, though the protective effect differed between male and female animals. That gut-brain link helps explain why inflammatory bowel disease patients so often report fatigue, brain fog, and mood changes alongside their digestive symptoms.
Why This Matters Beyond The Lab
A recent narrative review pulled these threads together, framing creatine’s antioxidant and anti-inflammatory effects as a plausible, biologically grounded tool for gut health rather than a settled treatment. That distinction matters. The findings explain a mechanism; they do not yet prove a cure. Patients and doctors still need results from trials testing creatine directly in people diagnosed with Crohn’s disease or ulcerative colitis before anyone changes treatment plans.
The safety case, at least, is already well established. Creatine monohydrate is recognized as safe by the Food and Drug Administration and has decades of use data behind it, with mild digestive upset remaining the most commonly reported side effect. That track record gives researchers a head start. If future human trials confirm what cells, organoids, and animals are already showing, a cheap supplement sitting in gym bags nationwide could become a serious tool against one of medicine’s more stubborn inflammatory diseases.
Sources:
mindbodygreen.com, pubmed.ncbi.nlm.nih.gov, research-collection.ethz.ch, pubs.rsc.org, sciencedirect.com, ncbi.nlm.nih.gov, pnas.org, nccih.nih.gov

















